Technology

AI is poised to drastically change business as we know it. The technology has the potential to be the best or worst thing that happens to your company in the coming year. Here’s how to make the most of the opportunity.

Every day we seem to hear another news story about some government entity exploring how to regulate AI. Just last week, the EU finalized a new set of rules, but they are far from alone as other countries look to control the growth of the technology. With a broad set of rules looming, it represents […]

© 2023 TechCrunch. All rights reserved. For personal use only.

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Why the EU AI Act was so hard to agree on On Saturday, European Union lawmakers announced they’d finally agreed the terms of the final version of the EU AI Act, a major…

This article is from The Technocrat, MIT Technology Review’s weekly tech policy newsletter about power, politics, and Silicon Valley. To receive it in your inbox every Friday, sign up here. Update: On December 8, 2023, the EU AI Act was agreed on, after this story was written and sent as MIT Technology Review’s weekly tech…

The rise of digital automation technology has made starting a passive income side hustle easier and more accessible than ever before.

No one can predict the future, but  here at MIT Technology Review we spend much of our time thinking about what it might hold. One thing we know is that it’s especially hard to make predictions about technology. Most emerging technologies fizzle or flame out. Some start out as consumer devices but wind up finding…

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. The lucky break behind the first CRISPR treatment The world’s first commercial gene-editing treatment is set to start changing the lives of people with sickle-cell disease. It’s called Casgevy, and it was approved…

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. The human body is a labyrinth of vessels and tubing, full of barriers that are difficult to break through. That poses a serious hurdle for doctors.…

Josh Claman Contributor Share on X Josh Claman is the CEO of Accelsius, makers of direct-to-chip, two-phase cooling technology. An advocate for the power of transformative technology throughout his 30-year career, Mr. Claman has grown and repositioned businesses at Dell, NCR and AT&T. Most of the world’s top-valued private companies are software companies. That’s not surprising — innovations in AI, social […]

© 2023 TechCrunch. All rights reserved. For personal use only.